Related Experiment Video
Updated: Aug 9, 2026
13:24
A Procedure to Observe Context-induced Renewal of Pavlovian-conditioned Alcohol-seeking Behavior in Rats
Published on: September 19, 2014
Summary
This study highlights a combination therapy of sodium sulfacetamide, hydrocortisone, and sulfur for treating acne and seborrheic dermatitis. The safe and effective prescription treatment also shows promise for perioral dermatitis.
Area of Science:
- Dermatology and Cutaneous Medicine
Background:
- Sodium sulfacetamide, hydrocortisone, and sulfur combination therapy has a 20-year history of safety and efficacy.
- This combination is a prescription treatment for pustular acne and severe, refractory seborrheic dermatitis.
Purpose of the Study:
- To evaluate the efficacy and safety of sodium sulfacetamide, hydrocortisone, and sulfur combination therapy.
- To assess its utility as a concomitant therapy for perioral dermatitis.
Main Methods:
- Clinical evaluation of the combination therapy in patients with acne, seborrheic dermatitis, and perioral dermatitis.
Main Results:
- The combination therapy demonstrates outstanding efficacy and patient acceptance.
- It is highly effective as a concomitant therapy for perioral dermatitis.
- Achieves therapeutic goals without the irritation associated with retinoic acid and benzoyl peroxide.
Conclusions:
- The sodium sulfacetamide, hydrocortisone, and sulfur combination is a safe and effective prescription treatment for acne and seborrheic dermatitis.
- It presents a valuable therapeutic option for perioral dermatitis with a favorable side effect profile.
More Related Videos
Related Concept Videos
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...